{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:16:51Z","timestamp":1794651411093,"version":"4.9.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cutaneous leishmaniasis (CL) is a very common parasitic infection in subtropical areas worldwide. Throughout decades, there have been challenges in vaccine design and vaccination against CL. The present study introduced novel T-cell-based vaccine candidates containing IFN-\u03b3 Inducing epitopic fragments from <jats:italic>Leishmania major<\/jats:italic> (<jats:italic>L. major<\/jats:italic>) glycoprotein 46 (gp46), cathepsin L-like and B-like proteases, histone H2A, glucose-regulated protein 78 (grp78) and stress-inducible protein 1 (STI-1). For this aim, top-ranked human leukocyte antigen (HLA)-specific, IFN-\u03b3 Inducing, antigenic, CD<jats:sub>4<\/jats:sub><jats:sup>+<\/jats:sup> and CD<jats:sub>8<\/jats:sub><jats:sup>+<\/jats:sup> binders were highlighted. Four vaccine candidates were generated using different spacers (AAY, GPGPG, GDGDG) and adjuvants (RS-09 peptide, human IFN-\u03b3, a combination of both, <jats:italic>Mycobacterium tuberculosis<\/jats:italic> Resuscitation promoting factor E (RpfE)). Based on the immune simulation profile, those with RS-09 peptide (Leish-<jats:italic>App<\/jats:italic>) and RpfE (Leish-<jats:italic>Rpf<\/jats:italic>) elicited robust immune responses and their tertiary structure were further refined. Also, molecular docking of the selected vaccine models with the human toll-like receptor 4 showed proper interactions, particularly for Leish-<jats:italic>App<\/jats:italic>, for which molecular dynamics simulations showed a stable connection with TLR-4. Upon codon optimization, both models were finally ligated into the pET28a(\u2009+) vector. In conclusion, two potent multi-epitope vaccine candidates were designed against CL and evaluated using comprehensive in silico methods, while further wet experiments are, also, recommended.<\/jats:p>","DOI":"10.1038\/s41598-023-46408-1","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T17:02:17Z","timestamp":1699462937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Engineering and design of promising T-cell-based multi-epitope vaccine candidates against leishmaniasis"],"prefix":"10.1038","volume":"13","author":[{"given":"Esmaeil Roohparvar","family":"Basmenj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Arastonejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Mamizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Alem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"KhalatbariLimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadan","family":"Ghiabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khamesipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Majidiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Irannejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"46408_CR1","first-page":"CD007634","volume":"2018","author":"N Khanjani","year":"2018","unstructured":"Khanjani, N. et al. Vaccines for preventing cutaneous leishmaniasis. Cochrane Database Syst. Rev. 2018, CD007634 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"46408_CR2","unstructured":"WHO. Leishmaniasis Fact Sheet (Accessed 7\/13\/2023). (World Health Organization, 2023)."},{"key":"46408_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00430-021-00703-8","volume":"210","author":"MN Rostami","year":"2021","unstructured":"Rostami, M. N. & Khamesipour, A. Potential biomarkers of immune protection in human leishmaniasis. Med. Microbiol. Immunol. 210, 81\u2013100 (2021).","journal-title":"Med. Microbiol. Immunol."},{"key":"46408_CR4","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.ijantimicag.2010.06.023","volume":"36","author":"JAR Postigo","year":"2010","unstructured":"Postigo, J. A. R. Leishmaniasis in the world health organization eastern mediterranean region. Int. J. Antimicrob. Agents 36, S62\u2013S65 (2010).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"46408_CR5","unstructured":"Health, M. O. Statistics of cutaneous leishmaniasis in Iran: Hearing before National Leishmaniasis Committee, office of zoonoses, center of disease control, Ministry of Health and Medical Education; (Sep. 30, 2004). (2004)."},{"key":"46408_CR6","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1080\/14760584.2021.1990043","volume":"20","author":"PM Kaye","year":"2021","unstructured":"Kaye, P. M. et al. Overcoming roadblocks in the development of vaccines for leishmaniasis. Expert Rev. Vaccines 20, 1419\u20131430 (2021).","journal-title":"Expert Rev. Vaccines"},{"key":"46408_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/biohorizons\/hzp004","volume":"2","author":"N Dunning","year":"2009","unstructured":"Dunning, N. Leishmania vaccines: From leishmanization to the era of DNA technology. Bioscience horizons 2, 73\u201382 (2009).","journal-title":"Bioscience horizons"},{"key":"46408_CR8","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.intimp.2011.05.008","volume":"11","author":"R Nagill","year":"2011","unstructured":"Nagill, R. & Kaur, S. Vaccine candidates for leishmaniasis: A review. Int. Immunopharmacol. 11, 1464\u20131488 (2011).","journal-title":"Int. Immunopharmacol."},{"key":"46408_CR9","doi-asserted-by":"publisher","first-page":"2603730","DOI":"10.1155\/2019\/2603730","volume":"2019","author":"\u00c1 Gabriel","year":"2019","unstructured":"Gabriel, \u00c1. et al. Cutaneous leishmaniasis: The complexity of host\u2019s effective immune response against a polymorphic parasitic disease. J. Immunol. Res. 2019, 2603730 (2019).","journal-title":"J. Immunol. Res."},{"key":"46408_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0020-7519(97)00169-0","volume":"28","author":"C Bogdan","year":"1998","unstructured":"Bogdan, C. & R\u00f6llinghoff, M. The immune response to Leishmania: Mechanisms of parasite control and evasion. Int. J. Parasitol. 28, 121\u2013134 (1998).","journal-title":"Int. J. Parasitol."},{"key":"46408_CR11","doi-asserted-by":"publisher","unstructured":"Zhang, Y. et al. Metabotropic glutamate receptor 5-related autoimmune encephalitis with reversible splenial lesion syndrome following SARS-CoV-2 vaccination. Medicine 102(7), e32971. https:\/\/doi.org\/10.1097\/MD.0000000000032971 (2023).","DOI":"10.1097\/MD.0000000000032971"},{"key":"46408_CR12","doi-asserted-by":"publisher","first-page":"fuad004","DOI":"10.1093\/femsre\/fuad004","volume":"47","author":"SJ Goodswen","year":"2023","unstructured":"Goodswen, S. J., Kennedy, P. J. & Ellis, J. T. A guide to current methodology and usage of reverse vaccinology towards in silico vaccine discovery. FEMS Microbiol. Rev. 47, fuad004 (2023).","journal-title":"FEMS Microbiol. Rev."},{"key":"46408_CR13","doi-asserted-by":"publisher","unstructured":"Hu, F. et al. Spatiotemporal evolution of online attention to vaccines since 2011: an empirical study in China. Front. Public Health 10, 949482. https:\/\/doi.org\/10.3389\/fpubh.2022.949482 (2022).","DOI":"10.3389\/fpubh.2022.949482"},{"key":"46408_CR14","doi-asserted-by":"crossref","unstructured":"Cui, Y. et al. MiR29a-3p improves acute lung injury by reducing alveolar epithelial cel PANoptosis. Aging dis. (2022).","DOI":"10.14336\/AD.2021.1023"},{"key":"46408_CR15","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.3389\/fimmu.2019.02776","volume":"10","author":"R Moxon","year":"2019","unstructured":"Moxon, R., Reche, P. A. & Rappuoli, R. Reverse vaccinology. Front. Immunol. 10, 2776 (2019).","journal-title":"Front. Immunol."},{"key":"46408_CR16","doi-asserted-by":"crossref","unstructured":"Xie, X. et al. New theoretical ISM-K2 Bayesian network model for evaluating vaccination effectiveness. J. Ambient Intelligence and Humanized Comput. (2023).","DOI":"10.1007\/s12652-022-04199-9"},{"key":"46408_CR17","doi-asserted-by":"publisher","unstructured":"Zhang, Q. et al. X-linked Charcot-Marie-Tooth disease after SARS-CoV-2 vaccination mimicked stroke-like episodes: A case report. World J. Clin. Cases 11(2), 464\u2013471. https:\/\/doi.org\/10.12998\/wjcc.v11.i2.464 (2023).","DOI":"10.12998\/wjcc.v11.i2.464"},{"key":"46408_CR18","doi-asserted-by":"publisher","unstructured":"Yi, Z. et al. Propofol attenuates mast cell degranulation via inhibiting the miR\u2011221\/PI3K\/Akt\/Ca2+ pathway. Exp. Ther. Med.\nhttps:\/\/doi.org\/10.3892\/etm.2018.6317 (2018).","DOI":"10.3892\/etm.2018.6317"},{"key":"46408_CR19","doi-asserted-by":"publisher","first-page":"1052478","DOI":"10.3389\/fmicb.2022.1052478","volume":"13","author":"CA Knight","year":"2023","unstructured":"Knight, C. A. et al. Leishmaniasis: Recent epidemiological studies in the Middle East. Front. Microbiol. 13, 1052478 (2023).","journal-title":"Front. Microbiol."},{"key":"46408_CR20","doi-asserted-by":"publisher","first-page":"e0009742","DOI":"10.1371\/journal.pntd.0009742","volume":"15","author":"S Malvolti","year":"2021","unstructured":"Malvolti, S., Malhame, M., Mantel, C. F., Le Rutte, E. A. & Kaye, P. M. Human leishmaniasis vaccines: Use cases, target population and potential global demand. PLoS Negl. Trop. Dis. 15, e0009742. https:\/\/doi.org\/10.1371\/journal.pntd.0009742 (2021).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"46408_CR21","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","volume":"23","author":"A Khamesipour","year":"2005","unstructured":"Khamesipour, A. et al. Leishmanization: Use of an old method for evaluation of candidate vaccines against leishmaniasis. Vaccine 23, 3642\u20133648 (2005).","journal-title":"Vaccine"},{"key":"46408_CR22","doi-asserted-by":"publisher","first-page":"105173","DOI":"10.1016\/j.actatropica.2019.105173","volume":"200","author":"M Mohebali","year":"2019","unstructured":"Mohebali, M., Nadim, A. & Khamesipour, A. An overview of leishmanization experience: A successful control measure and a tool to evaluate candidate vaccines. Acta Tropica 200, 105173 (2019).","journal-title":"Acta Tropica"},{"key":"46408_CR23","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.vaccine.2006.11.057","volume":"25","author":"L Parra","year":"2007","unstructured":"Parra, L. et al. Safety trial using the Leishmune\u00ae vaccine against canine visceral leishmaniasis in Brazil. Vaccine 25, 2180\u20132186 (2007).","journal-title":"Vaccine"},{"key":"46408_CR24","doi-asserted-by":"publisher","first-page":"892817","DOI":"10.1155\/2012\/892817","volume":"2012","author":"KJ Evans","year":"2012","unstructured":"Evans, K. J. & Kedzierski, L. Development of vaccines against visceral leishmaniasis. J. Trop. Med. 2012, 892817 (2012).","journal-title":"J. Trop. Med."},{"key":"46408_CR25","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.4049\/jimmunol.145.7.2281","volume":"145","author":"D Yang","year":"1990","unstructured":"Yang, D. et al. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J. Immunol. (Baltimore, Md.: 1950) 145, 2281\u20132285 (1990).","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"46408_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-9292-6-7","volume":"6","author":"H Ghalib","year":"2007","unstructured":"Ghalib, H. & Modabber, F. Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis. Kinetoplastid Biol. Dis. 6, 1\u201314 (2007).","journal-title":"Kinetoplastid Biol. Dis."},{"key":"46408_CR27","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3389\/fimmu.2018.01043","volume":"9","author":"RC De Brito","year":"2018","unstructured":"De Brito, R. C. et al. Peptide vaccines for leishmaniasis. Front. Immunol. 9, 1043 (2018).","journal-title":"Front. Immunol."},{"key":"46408_CR28","doi-asserted-by":"publisher","first-page":"e1610","DOI":"10.1371\/journal.pntd.0001610","volume":"6","author":"R Gomes","year":"2012","unstructured":"Gomes, R. et al. KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi. PLoS Negl. Trop. Dis. 6, e1610 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"46408_CR29","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1016\/j.vaccine.2012.03.068","volume":"30","author":"B Singh","year":"2012","unstructured":"Singh, B. & Sundar, S. Leishmaniasis: Vaccine candidates and perspectives. Vaccine 30, 3834\u20133842 (2012).","journal-title":"Vaccine"},{"key":"46408_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1574-695X.1998.tb01129.x","volume":"20","author":"M Kemp","year":"1998","unstructured":"Kemp, M. et al. The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major. FEMS Immunol. Med. Microbiol. 20, 209\u2013218 (1998).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"46408_CR31","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1128\/iai.56.12.3272-3279.1988","volume":"56","author":"J Champsi","year":"1988","unstructured":"Champsi, J. & McMahon-Pratt, D. Membrane glycoprotein M-2 protects against Leishmania amazonensis infection. Infect. Immun. 56, 3272\u20133279 (1988).","journal-title":"Infect. Immun."},{"key":"46408_CR32","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1128\/iai.63.11.4261-4267.1995","volume":"63","author":"E Handman","year":"1995","unstructured":"Handman, E., Symons, F. M., Baldwin, T. M., Curtis, J. M. & Scheerlinck, J. Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response. Infect. Immun. 63, 4261\u20134267 (1995).","journal-title":"Infect. Immun."},{"key":"46408_CR33","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.4049\/jimmunol.157.11.5034","volume":"157","author":"JR Webb","year":"1996","unstructured":"Webb, J. R., Kaufmann, D., Campos-Neto, A. & Reed, S. G. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. J. Immunol (Baltimore, Md.: 1950) 157, 5034\u20135041 (1996).","journal-title":"J. Immunol (Baltimore, Md.: 1950)"},{"key":"46408_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.exppara.2006.07.002","volume":"115","author":"A Badiee","year":"2007","unstructured":"Badiee, A., Jaafari, M. R. & Khamesipour, A. Leishmania major: Immune response in BALB\/c mice immunized with stress-inducible protein 1 encapsulated in liposomes. Exp. Parasitol. 115, 127\u2013134 (2007).","journal-title":"Exp. Parasitol."},{"key":"46408_CR35","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1128\/IAI.69.6.4103-4108.2001","volume":"69","author":"A Campos-Neto","year":"2001","unstructured":"Campos-Neto, A. et al. Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease. Infect. Immun. 69, 4103\u20134108 (2001).","journal-title":"Infect. Immun."},{"key":"46408_CR36","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1128\/IAI.70.6.2828-2836.2002","volume":"70","author":"A Campos-Neto","year":"2002","unstructured":"Campos-Neto, A. et al. Vaccination with plasmid DNA encoding TSA\/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB\/c mice. Infect. Immun. 70, 2828\u20132836 (2002).","journal-title":"Infect. Immun."},{"key":"46408_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0167-4838(01)00240-0","volume":"1549","author":"AT Jensen","year":"2001","unstructured":"Jensen, A. T., Curtis, J., Montgomery, J., Handman, E. & Theander, T. G. Molecular and immunological characterisation of the glucose regulated protein 78 of Leishmania donovani. Biochim. Biophys. Acta (BBA)-Protein Struct. Mol. Enzymol. 1549, 73\u201387 (2001).","journal-title":"Biochim. Biophys. Acta (BBA)-Protein Struct. Mol. Enzymol."},{"key":"46408_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-6851(03)00211-1","volume":"132","author":"C Yao","year":"2003","unstructured":"Yao, C., Donelson, J. E. & Wilson, M. E. The major surface protease (MSP or GP63) of Leishmania sp. Biosynthesis, regulation of expression, and function. Mol. Biochem. Parasitol. 132, 1\u201316 (2003).","journal-title":"Mol. Biochem. Parasitol."},{"key":"46408_CR39","doi-asserted-by":"publisher","first-page":"11015","DOI":"10.1073\/pnas.96.20.11015","volume":"96","author":"PM Selzer","year":"1999","unstructured":"Selzer, P. M. et al. Cysteine protease inhibitors as chemotherapy: Lessons from a parasite target. Proc. Natl. Acad. Sci. 96, 11015\u201311022 (1999).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"46408_CR40","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1016\/S0264-410X(01)00081-0","volume":"19","author":"S Rafati","year":"2001","unstructured":"Rafati, S., Salmanian, A.-H., Taheri, T., Vafa, M. & Fasel, N. A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major. Vaccine 19, 3369\u20133375 (2001).","journal-title":"Vaccine"},{"key":"46408_CR41","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri.2016.72","volume":"16","author":"P Scott","year":"2016","unstructured":"Scott, P. & Novais, F. O. Cutaneous leishmaniasis: Immune responses in protection and pathogenesis. Nat. Rev. Immunol. 16, 581\u2013592 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"46408_CR42","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.drudis.2020.03.006","volume":"25","author":"S Parvizpour","year":"2020","unstructured":"Parvizpour, S., Pourseif, M. M., Razmara, J., Rafi, M. A. & Omidi, Y. Epitope-based vaccine design: A comprehensive overview of bioinformatics approaches. Drug Discov. Today 25, 1034\u20131042 (2020).","journal-title":"Drug Discov. Today"},{"key":"46408_CR43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s10989-022-10438-6","volume":"28","author":"M Hasan","year":"2022","unstructured":"Hasan, M. & Mia, M. Exploratory algorithm of a multi-epitope-based subunit vaccine candidate against cryptosporidium hominis: Reverse vaccinology-based immunoinformatic approach. Int. J. Peptide Res. Ther. 28, 134 (2022).","journal-title":"Int. J. Peptide Res. Ther."},{"key":"46408_CR44","doi-asserted-by":"publisher","first-page":"24485","DOI":"10.1038\/s41598-021-03932-2","volume":"11","author":"H Tarrahimofrad","year":"2021","unstructured":"Tarrahimofrad, H., Rahimnahal, S., Zamani, J., Jahangirian, E. & Aminzadeh, S. Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9. Sci. Rep. 11, 24485 (2021).","journal-title":"Sci. Rep."},{"key":"46408_CR45","doi-asserted-by":"publisher","unstructured":"Feng, S., Song, G., Liu, L., Liu, W., Liang, G., Song, Z. Allergen-specific immunotherapy induces\nmonocyte-derived dendritic cells but attenuates their maturation and cytokine production in the lesional skin of an atopic\ndermatitis mouse model. J. Dermatology https:\/\/doi.org\/10.1111\/1346-8138.16582 (2022).","DOI":"10.1111\/1346-8138.16582"},{"key":"46408_CR46","doi-asserted-by":"crossref","unstructured":"Liu, L., Song, G., Song, Z. Intrinsic Atopic Dermatitis and Extrinsic Atopic Dermatitis: Similarities and Differences. Clinical, Cosmetic\nand Investigational Dermatology, (2022).","DOI":"10.2147\/CCID.S391360"},{"key":"46408_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-08842-w","volume":"7","author":"N Khatoon","year":"2017","unstructured":"Khatoon, N., Pandey, R. K. & Prajapati, V. K. Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach. Sci. Rep. 7, 1\u201312 (2017).","journal-title":"Sci. Rep."},{"key":"46408_CR48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11756-021-00934-3","volume":"77","author":"M Shams","year":"2022","unstructured":"Shams, M. et al. Engineering a multi-epitope vaccine candidate against Leishmania infantum using comprehensive immunoinformatics methods. Biologia 77, 277\u2013289 (2022).","journal-title":"Biologia"},{"key":"46408_CR49","doi-asserted-by":"publisher","first-page":"105423","DOI":"10.1016\/j.ejps.2020.105423","volume":"152","author":"M Rabienia","year":"2020","unstructured":"Rabienia, M. et al. Exploring membrane proteins of Leishmania major to design a new multi-epitope vaccine using immunoinformatics approach. Eur. J. Pharm. Sci. 152, 105423 (2020).","journal-title":"Eur. J. Pharm. Sci."},{"key":"46408_CR50","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/protein\/14.8.529","volume":"14","author":"R Arai","year":"2001","unstructured":"Arai, R., Ueda, H., Kitayama, A., Kamiya, N. & Nagamune, T. Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng. 14, 529\u2013532 (2001).","journal-title":"Protein Eng."},{"key":"46408_CR51","doi-asserted-by":"publisher","first-page":"113917","DOI":"10.1016\/j.ejmech.2021.113917","volume":"227","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. Built-in adjuvants for use in vaccines. Eur. J. Med. Chem. 227, 113917 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"46408_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-020-04064-8","volume":"13","author":"MAA Khan","year":"2020","unstructured":"Khan, M. A. A. et al. An immunoinformatic approach driven by experimental proteomics: In silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes. Parasites Vectors 13, 1\u201321 (2020).","journal-title":"Parasites Vectors"},{"key":"46408_CR53","doi-asserted-by":"publisher","first-page":"e8795","DOI":"10.7717\/peerj.8795","volume":"8","author":"OS Onile","year":"2020","unstructured":"Onile, O. S., Fadahunsi, A. I., Adekunle, A. A., Oyeyemi, B. F. & Anumudu, C. I. An immunoinformatics approach for the design of a multi-epitope subunit vaccine for urogenital schistosomiasis. PeerJ 8, e8795 (2020).","journal-title":"PeerJ"},{"key":"46408_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-57906-x","volume":"10","author":"S Tarang","year":"2020","unstructured":"Tarang, S. et al. In silico design of a multivalent vaccine against Candida albicans. Sci. Rep. 10, 1\u20137 (2020).","journal-title":"Sci. Rep."},{"key":"46408_CR55","doi-asserted-by":"publisher","first-page":"e13677","DOI":"10.1371\/journal.pone.0013677","volume":"5","author":"RN Coler","year":"2010","unstructured":"Coler, R. N. et al. A synthetic adjuvant to enhance and expand immune responses to influenza vaccines. PloS one 5, e13677 (2010).","journal-title":"PloS one"},{"key":"46408_CR56","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1002\/eji.201445329","volume":"45","author":"HG Choi","year":"2015","unstructured":"Choi, H. G. et al. Mycobacterium tuberculosis RpfE promotes simultaneous Th1-and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells. Eur. J. Immunol. 45, 1957\u20131971 (2015).","journal-title":"Eur. J. Immunol."},{"key":"46408_CR57","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/107999000312450","volume":"20","author":"J Kim","year":"2000","unstructured":"Kim, J. et al. Coimmunization with IFN-gamma or IL-2, but not IL-13 or IL-4 cDNA can enhance Th1-type DNA vaccine-induced immune responses in vivo. J. Interf. Cytokine Res.: Off. J. Int. Soc. Interf. Cytokine Res. 20, 311\u2013319 (2000).","journal-title":"J. Interf. Cytokine Res.: Off. J. Int. Soc. Interf. Cytokine Res."},{"key":"46408_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-4-44","volume":"4","author":"R Su\u00e1rez-M\u00e9ndez","year":"2004","unstructured":"Su\u00e1rez-M\u00e9ndez, R. et al. Adjuvant interferon gamma in patients with drug\u2013resistant pulmonary tuberculosis: A pilot study. BMC Infect. Dis. 4, 1\u20138 (2004).","journal-title":"BMC Infect. Dis."},{"key":"46408_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41434-021-00270-w","volume":"30","author":"BF Zanetti","year":"2023","unstructured":"Zanetti, B. F., Ferreira, C. P., Vasconcelos, J. R. C. & Han, S. W. Adjuvant properties of IFN-\u03b3 and GM-CSF in the scFv6. C4 DNA vaccine against CEA-expressing tumors. Gene Ther. 30, 41\u201350 (2023).","journal-title":"Gene Ther."},{"key":"46408_CR60","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s10989-019-09949-6","volume":"26","author":"P Hashemzadeh","year":"2020","unstructured":"Hashemzadeh, P., Ghorbanzadeh, V., Lashgarian, H. E., Kheirandish, F. & Dariushnejad, H. Harnessing bioinformatic approaches to design novel multi-epitope subunit vaccine against Leishmania infantum. Int. J. Pept. Res. Ther. 26, 1417\u20131428 (2020).","journal-title":"Int. J. Pept. Res. Ther."},{"key":"46408_CR61","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/20477724.2020.1842976","volume":"114","author":"S Yadav","year":"2020","unstructured":"Yadav, S. et al. Design of a multi-epitope subunit vaccine for immune-protection against Leishmania parasite. Pathog. Glob. Health 114, 471\u2013481 (2020).","journal-title":"Pathog. Glob. Health"},{"key":"46408_CR62","doi-asserted-by":"publisher","first-page":"107157","DOI":"10.1016\/j.compbiolchem.2019.107157","volume":"83","author":"G Rop\u00f3n-Palacios","year":"2019","unstructured":"Rop\u00f3n-Palacios, G., Chenet-Zuta, M. E., Otazu, K., Olivos-Ramirez, G. E. & Camps, I. Novel multi-epitope protein containing conserved epitopes from different Leishmania species as potential vaccine candidate: Integrated immunoinformatics and molecular dynamics approach. Comput. Biol. Chem. 83, 107157 (2019).","journal-title":"Comput. Biol. Chem."},{"key":"46408_CR63","doi-asserted-by":"crossref","unstructured":"UniProt. UniProt: A worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506\u2013D515 (2019).","DOI":"10.1093\/nar\/gky1049"},{"key":"46408_CR64","doi-asserted-by":"publisher","first-page":"D339","DOI":"10.1093\/nar\/gky1006","volume":"47","author":"R Vita","year":"2019","unstructured":"Vita, R. et al. The immune epitope database (IEDB): 2018 update. Nucleic Acids Res. 47, D339\u2013D343 (2019).","journal-title":"Nucleic Acids Res."},{"key":"46408_CR65","doi-asserted-by":"publisher","first-page":"65","DOI":"10.34172\/bi.2021.11","volume":"11","author":"MM Pourseif","year":"2021","unstructured":"Pourseif, M. M. et al. A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: Development of self-amplifying mRNA and peptide vaccines. BioImpacts: BI 11, 65 (2021).","journal-title":"BioImpacts: BI"},{"key":"46408_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov, I., Bangov, I., Flower, D. R. & Doytchinova, I. AllerTOP v. 2\u2014a server for in silico prediction of allergens. J. Mol. Model. 20, 1\u20136 (2014).","journal-title":"J. Mol. Model."},{"key":"46408_CR67","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","volume":"30","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov, I., Naneva, L., Doytchinova, I. & Bangov, I. AllergenFP: Allergenicity prediction by descriptor fingerprints. Bioinformatics 30, 846\u2013851 (2014).","journal-title":"Bioinformatics"},{"key":"46408_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 8, 1\u20137 (2007).","journal-title":"BMC Bioinform."},{"key":"46408_CR69","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","volume":"33","author":"M Hebditch","year":"2017","unstructured":"Hebditch, M., Carballo-Amador, M. A., Charonis, S., Curtis, R. & Warwicker, J. Protein\u2013Sol: A web tool for predicting protein solubility from sequence. Bioinformatics 33, 3098\u20133100 (2017).","journal-title":"Bioinformatics"},{"key":"46408_CR70","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-890-0:571","volume-title":"Protein identification and analysis tools on the ExPASy server","author":"E Gasteiger","year":"2005","unstructured":"Gasteiger, E. et al. Protein identification and analysis tools on the ExPASy server (Springer, 2005)."},{"key":"46408_CR71","doi-asserted-by":"crossref","unstructured":"Garnier, J., Gibrat, J.-F. & Robson, B. in Methods Enzymol. Vol. 266, 540\u2013553 (Elsevier, 1996).","DOI":"10.1016\/S0076-6879(96)66034-0"},{"key":"46408_CR72","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy, A., Kucukural, A. & Zhang, Y. I-TASSER: A unified platform for automated protein structure and function prediction. Nat. Protoc. 5, 725\u2013738 (2010).","journal-title":"Nat. Protoc."},{"key":"46408_CR73","doi-asserted-by":"publisher","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin, N., Lund, O., Bernaschi, M. & Castiglione, F. Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system. PLoS One 5, e9862 (2010).","journal-title":"PLoS One"},{"key":"46408_CR74","doi-asserted-by":"publisher","first-page":"W384","DOI":"10.1093\/nar\/gkt458","volume":"41","author":"L Heo","year":"2013","unstructured":"Heo, L., Park, H. & Seok, C. GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Res. 41, W384\u2013W388 (2013).","journal-title":"Nucleic Acids Res."},{"key":"46408_CR75","unstructured":"Laskowski, R., MacArthur, M. & Thornton, J. in International Tables for Crystallography Vol. F (eds M.G. Rossmann & E. Arnold) 722\u2013725 (2006)."},{"key":"46408_CR76","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov, D. et al. The ClusPro web server for protein\u2013protein docking. Nat. Protoc. 12, 255 (2017).","journal-title":"Nat. Protoc."},{"key":"46408_CR77","doi-asserted-by":"publisher","first-page":"2644667","DOI":"10.1155\/2022\/2644667","volume":"2022","author":"M Shams","year":"2022","unstructured":"Shams, M. et al. Towards the first multiepitope vaccine candidate against Neospora caninum in mouse model: Immunoinformatic standpoint. BioMed Res. Int. 2022, 2644667 (2022).","journal-title":"BioMed Res. Int."},{"key":"46408_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471250953.bi0129s53","volume":"53","author":"S Pundir","year":"2016","unstructured":"Pundir, S., Martin, M. J., O\u2019Donovan, C. & Consortium, U. UniProt tools. Curr. Protoc. Bioinform. 53, 1\u201329 (2016).","journal-title":"Curr. Protoc. Bioinform."},{"key":"46408_CR79","doi-asserted-by":"publisher","first-page":"W526","DOI":"10.1093\/nar\/gki376","volume":"33","author":"A Grote","year":"2005","unstructured":"Grote, A. et al. JCat: A novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 33, W526\u2013W531 (2005).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46408-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46408-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46408-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T18:04:31Z","timestamp":1699466671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46408-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46408"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46408-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"13 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19421"}}